NATCO Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited (NATCO), has completed the acquisition of Dash Pharmaceuticals LLC (Dash), a New Jersey based entity. Pursuant to this, Dash will become a 100% wholly owned subsidiary of NATCO Pharma Inc. and a step-down subsidiary of NATCO. The acquisition amount paid is US$ 18…